Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Annals of Laboratory Medicine|July 25, 2015
Phenotypic and genotypic analysis of anti-tuberculosis drug resistance in Mycobacterium tuberculosis isolates in MyanmarWah Wah Aung, Phyu Win Ei, Wint Wint Nyunt, et al.
Diagnostic Microbiology and Infectious Disease|September 22, 2018
Drug susceptibility patterns of Mycobacterium abscessus and Mycobacterium massiliense isolated from respiratory specimensEun Hye Cho, Hee Jae Huh, Dong Joon Song, et al.
Genome Announcements|March 22, 2013
Complete Genome Sequence of Mycobacterium bovis BCG Korea, the Korean Vaccine Strain for Substantial ProductionSun Myung Joung, Sung Joo Jeon, Young Ju Lim, et al.
Chest|May 12, 2016
Oral Macrolide Therapy Following Short-term Combination Antibiotic Treatment of Mycobacterium massiliense Lung DiseaseWon-Jung Koh, Byeong-Ho Jeong, Kyeongman Jeon, et al.
Scandinavian Journal of Infectious Diseases|September 14, 2007
Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing AcinetobacterYeon-A Kim, Jun Yong Choi, Chang Ki Kim, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2016
Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung DiseaseSeong Mi Moon, Hye Yun Park, Su-Young Kim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 25, 2016
Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung DiseaseWon-Jung Koh, Byeong-Ho Jeong, Su-Young Kim, et al.
Trials|January 18, 2019
Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trialMyungsun Lee, Jeongha Mok, Deog Kyeom Kim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 25, 2014
Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosisJ Peter Cegielski, Tracy Dalton, Martin Yagui, et al.
Lancet (London, England)|September 4, 2012
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort studyTracy Dalton, Peter Cegielski, Somsak Akksilp, et al.
Pageof 9